Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Fort Collins, Colorado 80528


Phase II trial of the silibin containing cream, Difinsa53 to determine efficacy in delaying, ameliorating, or preventing radiation dermatitis in patients with breast cancer undergoing whole breast radiation.

Study summary:

The proposed study seeks to evaluate the efficacy of DIFINISA53™, a safe silibin-based skin cream, on preventing radiation dermatitis (RD) when compared to an over the counter ointment, Aquaphor, in women undergoing radiation therapy for breast cancer following lumpectomy or mastectomy surgery. Presently there is no known fully effective topical protectant from RD and there is no consensus among radiation oncologists on how best to treat RD. This study seeks to identify a more effective option for patients receiving radiation therapy. Each participant will apply the DIFINISA53™ cream to one area of the treated skin and Aquaphor to another area of treated skin. Skin reactions will be evaluated using medical professional assessment, participant assessment, and photographic assessment by a third party.


Inclusion Criteria: - Female patients 18 years and older - Pathologic diagnosis of breast cancer requiring radiation therapy to whole breast - Able to apply lotion to treatment area at least twice daily during radiation course - All surgical sites healed - No evidence of infection - No history of sensitivity to any component in Aquaphor or Difensa53 Exclusion Criteria: - Prior history of radiation therapy (RT) to that site - Known dermatologic conditions affecting skin in radiation port - Concurrent chemotherapy - Skin infection in radiation port - History of sensitivity to Aquaphor or Difensa53 component



Primary Contact:

Principal Investigator
Joshua Petit, MD
UC Health, Poudre Valley Hospital

Backup Contact:


Location Contact:

Fort Collins, Colorado 80528
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.